Related references
Note: Only part of the references are listed.Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function
Eric W. Lumsden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine
Jaclyn N. Highland et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine
Kenichi Fukumoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
Yukihiko Shirayama et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit
N. Yao et al.
MOLECULAR PSYCHIATRY (2018)
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling
L. Cavalleri et al.
MOLECULAR PSYCHIATRY (2018)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Common Neurotransmission Recruited in (R,S)-Ketamine and (2R, 6R)-Hydroxynorketamine-Induced Sustained Antidepressant-like Effects
Thu Ha Pham et al.
BIOLOGICAL PSYCHIATRY (2018)
Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2018)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Convergent Mechanisms Underlying Rapid Antidepressant Action
Panos Zanos et al.
CNS DRUGS (2018)
Mechanisms of ketamine action as an antidepressant
P. Zanos et al.
MOLECULAR PSYCHIATRY (2018)
(2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray
Dylan Chou et al.
NEUROPHARMACOLOGY (2018)
(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice
Jun-ichi Yamaguchi et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos et al.
PHARMACOLOGICAL REVIEWS (2018)
Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine
Zheng Tian et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2018)
Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model
Kai Zhang et al.
SCIENTIFIC REPORTS (2018)
Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model
Kai Zhang et al.
PSYCHOPHARMACOLOGY (2018)
(2R,6R)-Hydroxynorketamine promotes dendrite outgrowth in human inducible pluripotent stem cell-derived neurons through AMPA receptor with timing and exposure compatible with ketamine infusion pharmacokinetics in humans
Ginetta Collo et al.
NEUROREPORT (2018)
Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression
Yukihiko Shirayama et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine
Kenichi Fukumoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Identifying fast-onset antidepressants using rodent models
M. J. Ramaker et al.
MOLECULAR PSYCHIATRY (2017)
Effects of a ketamine metabolite on synaptic NMDAR function
Kanzo Suzuki et al.
NATURE (2017)
Synthesis and N-Methyl-D-aspartate (NMDA) Receptor Activity of Ketamine Metabolites
Patrick J. Morris et al.
ORGANIC LETTERS (2017)
Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
Chun Yang et al.
TRANSLATIONAL PSYCHIATRY (2017)
A Negative Allosteric Modulator for alpha 5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice
Panos Zanos et al.
ENEURO (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
(R)-Ketamine Shows Greater Potency and Longer Lasting Antidepressant Effects Than Its Metabolite (2R,6R)-Hydroxynorketamine
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2017)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
A REVIEW OF KETAMINE ABUSE AND DIVERSION
Sean Sassano-Higgins et al.
DEPRESSION AND ANXIETY (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine
Chun Yang et al.
PSYCHIATRY RESEARCH (2016)
The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents
Adam L. Halberstadt et al.
PSYCHOPHARMACOLOGY (2016)
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
D. Jeffrey Newport et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
C. Yang et al.
TRANSLATIONAL PSYCHIATRY (2015)
Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression
Le-Ben Wan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
The distribution and clearance of (2S,6S)-hydroxynorketamine, an active ketamine metabolite, in Wistar rats
Ruin Moaddel et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition
Panos Zanos et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
R(-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
Ji-chun Zhang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors
Ruin Moaddel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro
Simone Portmann et al.
JOURNAL OF CHROMATOGRAPHY A (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Optimizing dosage of ketamine and xylazine in murine echocardiography
Qi Xu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
(±) ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics
Jackie Cilia et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate
Harvey J. Motulsky et al.
BMC BIOINFORMATICS (2006)
Share Paper
